Skip to main content

Transcriptomic profiling of cell-free and vesicular microRNAs from matched arterial and venous sera.

Hermann S, Buschmann D, Kirchner B, Borrmann M, Brandes F, Kotschote S, Bonin M, Lindemann A, Reithmair M, Schelling G, Pfaffl MW

Publication: J Extracell Vesicles (2019) • Vol 8 • Page 1670935PMID: 31632620View on PubMed

Purpose

This study compared microRNA (miRNA, miR) profiles, morphology, and protein levels of extracellular vesicles (EV) isolated from arterial and venous serum specimens; crude EVs and those purified by size exclusion chromatography (SEC).

Conclusion

Arterial and venous serum specimens produced similar RNA yields, a comparable mean proportion of miRNA reads, and very strongly correlated miRNA profiles; however, the mean proportion of miRNA reads was much lower in RNA from SEC-purified EVs than crude EVs.  Principal component analysis (PCA) revealed overlapping expression profiles of arterial and venous serum specimens regardless of whether EVs were purified. Among the ten most highly expressed miRNAs, variability was greater between patients than between arterial and venous specimens from the same patient indicating a limited effect of the location of blood sampling. Although no differentially expressed miRNAs were identified between arterial and venous specimens using purified EVs or crude EVs when the most stringent conditions were applied, under less stringent conditions 4 miRNAs were higher in venous than arterial crude EV specimens. Of these 4 miRNAs, real-time PCR analysis only confirmed higher mean levels of miR-493-5p in arterial compared to venous specimens.

Differences in morphology was limited to slightly smaller and less concentrated EVs in arterial specimens compared to venous specimens, regardless of purification, although purification did lead to lower EV concentrations in both venous and arterial specimens. Western blot analysis of SEC-purified EVs resulted in detection of alix, CD63, syntenin and CD81 in both arterial and venous specimens, and the expected lack of CNX indicated no cellular contamination.  ApoA1 and albumin were detected in both arterial and venous specimens at low levels despite not being enriched in EVs.

Studies (2)

Purpose

This study compared miRNA yields and profiles in crude and SEC-purified extracellular vesicles from case-matched arterial and venous serum specimens. The subjects included 20 cardiac surgery patients (15 with coronary artery disease and five with combined heart valve disease) of which fifteen also had hypertension, seven also had diabetes, and five had minor renal function impairment.  Blood was collected into S-monovette serum tubes simultaneously from an arterial line introduced into the radial artery and a central venous line in the internal jugular vein after induction of anesthesia. After a 30 min clot time, serum was obtained by centrifugation at 3,400 x g for 10 min and then aliquoted and stored at -80°C. Crude EVs were obtained using the miRCURY Exosome Isolation Kit-Serum and Plasma kit.  To investigate the effects of further purification, EVs from 14 patients were further purified using SEC. RNA was extracted from the EVs using miRCURY RNA Isolation Kit-Biofluids kit for NGS analysis and the miRNeasy Micro Kit for real-time PCR analysis. The elution step was repeated for each kit and the eluates were further concentrated by vacuum-induced centrifugal evaporation. RNA yield and size distribution were determined by Bioanalyzer.  cDNA libraries were made using the NEBNext Multiplex Small RNA Library Prep Set for Illumina after dilution of adapters and primers and sequenced on a 2100 Bioanalyzer using the DNA 1000 Kit and a HiSeq2500. miRNAs found to differ between arterial and venous specimens were verified by real-time RT-PCR using the miRCURY LNA RT and SYBR Green PCR Kits.

Summary of Findings

The amount of RNA obtained from crude and SEC-purified EVs was comparable in arterial and venous serum specimens. The mean proportion of miRNA reads was much lower for SEC-purified than crude EVs but were comparable among arterial and venous serum specimens (44.20% arterial in crude samples, 46.39% in venous crude samples, 9.51% in arterial purified EVs and 10.48% in venous purified EVs). miRNA profiles were very strongly correlated between venous and arterial specimens for both crude EVs (R2=0.9923) and SEC-purified EVs (R2=0.9992). Importantly, correlations between arterial and venous specimens remained very strong even when the lowest expressed (<10000 reads) miRNAs were considered (R2=0.9948 in crude EVS and R2=0.9943 in purified EVS). PCA analysis showed overlapping expression profiles in arterial and venous specimens regardless of EV SEC purification. However, while hierarchical clustering of crude EV specimens clustered by patient, clustering was less clear in SEC-purified EVs.  Among the ten most highly expressed miRNAs, variability was greater between patients than between arterial and venous specimens from the same patient indicating a limited effect of the location of blood sampling. Although no differentially expressed miRNAs were identified using the most stringent condition (baseMean≥50, absolute value of log2 fold change ≥1, and P-adjusted ≤0.05) regardless of whether EVs were crude or SEC-purified, when the least stringent conditions was applied miR-223-3p, miR-379-5p, miR-493-5p, miR-542-3p were higher in crude EVs isolated from venous as opposed to arterial specimens (baseMean ≥50, absolute value of log2 fold change ≥0.5, and P adjusted ≤0.1). However, this was not true for all specimens nor was it observed in SEC-purified EVs. Of theses 4 miRNAs, real-time PCR was only able to confirm higher average levels of miR-493-5p in arterial compared to venous specimens (2.37-fold, P=0.0014).

  • Biospecimens

    FluidBlood
    FluidSerum
  • Preservation Types

    Frozen
  • Diagnoses

    Coronary Artery Disease
    Diabetes Type 2
    Hypertension
    Other diagnoses
  • Platforms

    RNAAutomated electrophoresis/Bioanalyzer
    RNANext generation sequencing
    RNAReal-time qRT-PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnatomical location of blood draw
    Internal jugular vein
    Radial artery
    Biospecimen Aliquots and ComponentsBlood and blood products
    Crude extracellular vesicles
    Purified extracellular vesicles
    Next generation sequencing SpecificTechnology platform
    Real-time PCR